REG - Assura plc - Notice of Results & Retail Investor Presentation

AssuraAnnouncement

31/10/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241031:nRSe3003Ka&default-theme=true

RNS Number : 3003K  Assura PLC  31 October 2024

31 October 2024

Assura plc

Notice of Interim Results & Retail Investor Presentation

Assura plc ("the Company"), the UK's leading diversified healthcare REIT will
announce results for the six months ended 30 September 2024 on Thursday 14
November 2024.

A presentation for analysts and investors, immediately followed by a Q&A
with members of the senior management team, can be viewed at 10.00 am GMT at
the following link:

https://brrmedia.news/AGR_HY_24 (https://brrmedia.news/AGR_HY_24)

Additional Investor Presentation for Retail Investors via Investor Meet
Company

Assura plc is also pleased to announce that Jonathan Murphy and Jayne Cottam
will provide a live presentation relating to the Interim Results via Investor
Meet Company on 15 Nov 2024, 1.00pm GMT.

The presentation is open to all existing and potential shareholders. Questions
can be submitted pre-event via your Investor Meet Company dashboard up until
14 Nov 2024, 9.00am GMT, or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Assura
via:

https://www.investormeetcompany.com/assura-plc/register-investor
(https://www.investormeetcompany.com/assura-plc/register-investor)

Investors who already follow Assura on the Investor Meet Company platform will
automatically be invited.

- Ends -

 

For more information, please contact:

 Assura plc                                   Tel: 0161 515 2043
 David Purcell, Investor Relations Director   Email: Investor@assura.co.uk
 FGS Global                                   Tel: 0207 251 3801

                                            Email: Assura@fgsglobal.com
 Gordon Simpson
 Grace Whelan

 

Notes to Editors

Assura plc is the UK's leading diversified healthcare REIT. Assura enables
better health outcomes through its portfolio of more than 600 healthcare
buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the
EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7
billion and has a strong track record of growing financial returns and
dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare
buildings in our history, and at the heart of our strategy sits The Bigger
Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business
(G).

Further information is available at www.assuraplc.com
(http://www.assuraplc.com)

*EPRA is a registered trademark of the European Public Real Estate Association

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORWPGMGUUPCGMU